Uncategorized

Takeda leads wave of orexin drugs with potential to upend narcolepsy market

Takeda leads wave of orexin drugs with potential to upend narcolepsy market

Published

on

The FDA’s August approval of Takeda’s Orzeyful for treating the full set of narcolepsy symptoms initiated a new era in the sleep market.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version